Skip to main content
African Journal of Urology
Fig. 5 | African Journal of Urology

Fig. 5

From: Patency period of a metallic ureteral stent and its determinants in patients with malignant ureteral obstruction: a prospective review

Fig. 5

a Overall survival. b Overall stent patency. c Stent patency in patients with direct compression by solid mass and peritoneal metastasis. d Stent patency in patients with bilateral and unilateral obstruction. e Stent patency in patients with and without urinary tract infection (UTI). f Stent patency in patients with a normal serum creatinine level one week after placement of the polymer ureteral stent. g Stent patency by patient age (< 70 years old or not). h Stent patency by performance status (0 or not). i Stent patency by serum creatinine level before placement of the polymer ureteral stent (< 2 mg/dL or not)

Back to article page